1.1 Overview of OTC Medications and APIs

Commonly used over-the-counter drugs for pain management, fever control, and immunological support include paracetamol, aspirin, and vitamin C. Their accessibility and affordability make them a go-to option for mild ailments, especially in families and primary care settings.

Their widespread usage in self-medication, however, emphasizes the necessity of strict quality control procedures. Subpar or fake goods can provide major health hazards, such as toxicity or treatment failure, if they are not properly regulated.^1,2 To prevent toxicity or therapeutic failure, it is essential to keep API content within pharmacopeial bounds.

1.2 Necessity of API Quantification:

A key component of pharmaceutical quality control is the precise assessment of API content. Drug efficacy and patient safety may be jeopardized by variations in API concentration³. To guarantee constant quality in pharmaceutical products, regulatory bodies including the USFDA, WHO, and EMA require established methodologies for API analysis^4,5. These techniques involve strict testing procedures for stability, potency, and purity—all of which are essential for both medicinal efficacy and patient safety. To reduce batch-to-batch variability and stop adulteration, pharmacopeial standards (such as USP, EP, and IP) are enforced. Furthermore, improvements in analytical methods like mass spectrometry and HPLC have improved the ability to identify contaminants and fake goods. Good Manufacturing Practices (GMP) and routine audits serve to further strengthen accountability throughout the pharmaceutical supply chain.

1.3 Advantages of UV Spectrophotometry in Quality Control:

A quick, accurate, and reasonably priced method for measuring the amount of active pharmaceutical ingredients (APIs) in pharmaceutical formulations is UV spectrophotometry. Its basic idea is to measure how well drug molecules absorb UV or visible light, which enables quick and very accurate examination. UV spectrophotometry can be used routinely in academic, medical, and industrial labs because it doesn't require costly equipment or significant sample preparation like complicated chromatographic techniques do. The technique ensures accuracy, linearity, and repeatability by following pharmacopeial guidelines (such as USP, Ph. Eur.) for test validation. Furthermore, automated systems facilitate high-throughput analysis for quality control in large-scale production, while derivative and multi-wavelength spectrophotometry can improve selectivity in complex matrices.^6,7

1.4 Objective of the Review:

This study offers a thorough examination of UV spectrophotometric techniques for the calibration curve approach-based quantitative assay of vitamin C, aspirin, and paracetamol. To guarantee regulatory compliance, it methodically assesses important validation characteristics, such as linearity, precision, accuracy, and robustness, in line with ICH Q2(R1) criteria (USP, EMA). To improve assay reliability, practical factors including choosing the right solvent, minimizing interference, and determining the ideal wavelength are closely examined. The paper also looks at new developments that enhance sensitivity and selectivity in complicated formulations, like derivative spectroscopy, chemometric modeling, and miniature spectrophotometric systems. This book is an invaluable resource for pharmaceutical analyzers, researchers, and quality control specialists since it combines conventional approaches with contemporary advancements.

2. THEORETICAL BACKGROUND:

2.1 Principles of UV-Vis Absorption:

The foundation of UV-visible spectroscopy is the idea that molecules absorb ultraviolet or visible light, which moves electrons from their ground state energy levels to their excited state energy levels. Quantitative analysis is made possible by the Beer-Lambert law, which states that absorbance is proportional to concentration. Functional groups that show distinctive absorbance in the UV region, including carbonyl compounds (n→π transitions) and aromatic rings (π→π transitions), help identify substances. Extended π-electrons in conjugated systems exhibit bathochromic shifts, or red shifts, and solvent polarity can affect absorption maxima, or solvatochromism. Because of its sensitivity and quick analysis time, advanced applications include monitoring reaction kinetics, characterisation of nanoparticles, and validation of pharmaceutical assays.⁸

2.2 Beer-Lambert Law:

The Beer-Lambert law (A = εCL) provides the basis for quantitative analysis, where A is absorbance, ε is molar absorptivity, C is concentration, and L is path length⁹. This law is valid within a certain concentration range and assumes a linear relationship between absorbance and concentration.

2.3 Calibration Curve Method:

Plotting absorbance readings (y-axis) versus known concentrations (x-axis) of standard solutions creates a linear connection using the calibration curve approach, which usually complies with Beer-Lambert's law. By statistically treating the data points, this basic analytical method produces a regression equation (y = mx + c), where the intercept (c) denotes system bias and the slope (m) denotes sensitivity. Linearity is validated by the correlation coefficient (R2 > 0.995), and method dependability for quantifying unknown samples is ensured by error analysis (e.g., %RSD of residuals). To satisfy GLP criteria, contemporary implementations use software-based validation procedures and quality control standards. Because of its balance of precision, simplicity, and cost-effectiveness, this method is a mainstay in clinical diagnostics, environmental monitoring, and pharmaceutical analysis. It blends theoretical soundness with practical utility.¹⁰

3. DRUG PROFILES:

3.1 Paracetamol (Acetaminophen):

Because of its aromatic π→π* electronic transitions, paracetamol (acetaminophen), a first-line analgesic and antipyretic medication, has maximal UV absorption at 243-254nm, making it perfect for spectrophotometric quantification in pharmaceutical formulations. Glucuronidation and sulfation (Phase II processes) account for the majority of the compound's hepatic metabolism, with CYP2E1 oxidizing a minor portion to the hazardous intermediate NAPQI, which is often detoxified by glutathione conjugation. Intentional or unintentional overdoses (>10-15g) might deplete hepatic glutathione stores, resulting in NAPQI buildup and potentially deadly centrilobular necrosis, despite the drug's excellent safety profile at therapeutic levels (4 g/day max for people). The use of N-acetylcysteine is emphasized in current treatment procedures as an antidote to restore glutathione. The medicine's narrow therapeutic index and well-characterized UV spectrum highlight the significance of precise analytical techniques for therapeutic drug monitoring in clinical settings as well as quality control.^11,12

3.2 Aspirin (Acetylsalicylic Acid):

The quintessential NSAID, aspirin (acetylsalicylic acid), has distinctive UV absorption at 276nm, which is attributed to its benzene ring and carbonyl chromophores. This characteristic is often used in pharmaceutical quality control. Its structure's ester bond makes it especially vulnerable to hydrolytic breakdown in aqueous solutions, which produces acetic and salicylic acids. Heat, an alkaline pH, and humidity all speed up this reaction. Strict analytical procedures are required due to this intrinsic instability: freshly made solutions, pH-controlled solvents (ideally pH 2-3), and prompt spectrophotometric analysis to avoid artifact generation. According to current pharmacopeias (USP, EP), stability-indicating techniques must have a resolution of more than 2.0 in validated tests between aspirin and its breakdown products. The molecule is a significant case study in pharmaceutical analysis and formulation science due to its dual character as a chemical stability problem and a commonly utilized therapeutic drug (antiplatelet, analgesic, and antipyretic).¹³

3.3 Vitamin C (Ascorbic Acid):

Because of its conjugated enediol structure, vitamin C (L-ascorbic acid), a potent water-soluble antioxidant, exhibits maximal UV absorption at 265–270nm. This property makes it very valuable for quantitative examination in food and pharmaceutical samples. Because of its high labile nature, it requires careful handling procedures because it can undergo oxidative degradation and change into dehydroascorbic acid when exposed to light, heat, oxygen, or alkaline circumstances. Samples should be prepared in cold, oxygen-free solvents (such metaphosphoric acid) for precise spectrophotometric determination. They should also be examined right away and shielded from UV radiation while being processed. When further specificity is needed, the compound's redox characteristics also enable complementary analytical methods such iodometric titration or HPLC with electrochemical detection. Accurate measurement of vitamin C is essential for guaranteeing product efficacy in nutraceuticals, cosmetics, and medicinal formulations because of its key roles in collagen production, immunological response, and reactive oxygen species (ROS) scavenging.¹⁴

4. EXPERIMENTAL METHODOLOGY:

4.1 Preparing the Sample:

To get a quantity equal to the labelled API content, commercial tablets are ground into a powder and weighed. Before analysis, the samples are filtered to exclude excipients after being dissolved in ethanol or distilled water.¹⁵

4.2 Dilution and Solvent:

The drug's solubility and suitability for UV spectrophotometry determine the solvent to use. To bring sample concentrations inside the calibration curve's linear range, serial dilutions are carried out¹⁶.

4.3 Common and Practical Solutions:

Pure drug standards are used to create stock solutions, which are subsequently diluted to provide a variety of working standards. These are employed to examine the unidentified samples and produce the calibration curve ¹⁷.

4.4 Calibration Curve Construction:

The λ_max of each drug is used to quantify the absorbance of standard solutions. A calibration curve is produced by plotting absorbance against concentration, and unknown concentrations are estimated using the linear regression equation.¹⁸

5. SPECTROPHOTOMETRIC ANALYSIS:

5.1 Instrumentation and λ_max Selection:

For the best spectral resolution (1nm bandwidth), a thermostated double-beam UV-Vis spectrophotometer with deuterium and tungsten-halogen lamps is used. To reduce scattering effects, the device is calibrated using matrix-matched blank solutions and matched quartz cuvettes before analysis. In order to determine λ_max, standard solutions are scanned in the 200–400nm range at intervals of 0.5nm. When appropriate, first-derivative processing is used to identify typical absorption maxima for overlapping peaks. Validation processes are integrated into modern systems in accordance with USP <857> criteria.¹⁹

5.2 Measurement Protocol:

In order to obtain high-precision measurements:

· Quartz cuvettes of spectrophotometric quality (path length confirmed to ±0.01mm)

· Baseline adjustment at three wavelengths (λ_max ±5 nm) to account for matrix interference

· Warming up the lamp (≥30 minutes) and periodically checking the intensity with NIST-traceable holmium oxide filters.

· Absorbance readings are obtained in triplicate (n=5 for GMP compliance) with automatic outlier rejection (Grubbs' test, α=0.05). Savitzky-Golay smoothing is commonly used in data gathering software to improve signal-to-noise ratios.²⁰

5.3 Analytical Sensitivity and Linearity:

· Validation studies show:

· Linear dynamic range: 2–20µg/mL (with path length adjustment, this can be extended to 50µg/mL).

· The 95% confidence interval for correlation coefficients is R2 ≥0.9995.

· Sensitivity: ICH Q2-compliant, LOD 0.15µg/mL, LOQ 0.5µg/mL

· Youden's ruggedness testing (±2nm λ_max fluctuation, ±10% mobile phase pH) with ≤2% RSD in slope values is used to verify the resilience of the method.²¹

6. VALIDATION OF METHOD:

6.1 Linearity:

Analyzing at least six concentration levels (in triplicate) covering 50–150% of the target range (2–20μg/mL) is how the method's linearity is assessed. A statistical evaluation of the calibration curve is conducted using:

· R2≥0.999 is the correlation coefficient.

· RSS<0.5% is the residual sum of squares.

· Slope and intercept 95% confidence intervals

Beer-Lambert's law adherence is verified using Mandell's fitting test, with approval requirements needing ≤5% departure from theoretical values at every calibration point²².

6.2 Accuracy and Precision:

Spike-and-recovery tests are used to evaluate accuracy in placebo matrices at 80%, 100%, and 120% of the target concentration (n=9 per level). For pure pharmacological compounds, acceptable recovery limits are 98–102%, while for compounded medications, they are 95–105%.

Among the precision investigations are:

· Intra-day repeatability (n=6): RSD ≤1%

· Inter-day, analyst-to-analyst intermediate precision: RSD ≤2%

Before every run, the system's appropriateness is checked (RSD ≤1% for the reference standard)²³.

6.3 LOD and LOQ:

Limits for detection and quantification are established using:

Method of signal-to-noise (3:1 for LOD, 10:1 for LOQ)

Formulas for ICH Q2(R1): LOD = 3.3σ/S, LOQ = 10σ/S

where S is the calibration curve's slope and σ is the regression's residual standard deviation. Experimentally confirmed by successive dilution until peak integrity (LOQ precision RSD≤5%) is preserved²⁴.

6.4 Specificity and Robustness:

To measure robustness, purposeful deviations are used:

· pH (to within 0.5units)

· Composition of the mobile phase (±5% organic modifier)

· Wavelength of detection (±2nm)

· Temperature of the column (±5°C)

Confirmation of specificity is provided by:

· Studies of forced deterioration (photolysis, oxidative stress, acid/base)

· Resolution of chromatography (R>2.0 between the analyte and the closest peak)

· Peak purity analysis (purity angle < threshold, diode array detection)²⁵.

7. COMPARATIVE BRAND EVALUATION:

7.1 Analysis of Marketed Paracetamol Brands:

Ten commercial paracetamol brands' API contents were measured in comparison to USP/BP reference standards. Results showed:

· Label claims are 95.2–104.8% compliant (USP acceptability range: 90–110% for tablets).

· Variability from batch to batch ≤2.1% RSD (n = 3 batches per brand)

· There was relatively little excipient interference (placebo recovery = 98.5–101.2%).

· Interestingly, under accelerated stability tests (40°C/75% RH for 3 months), film-coated tablets demonstrated higher stability than powder formulations³.

7.2 Aspirin Brand Evaluation:

Because aspirin is prone to hydrolysis, samples were examined within two hours of dissolving at 37°C with 0.1N HCl:

· Compliance with label claims: 93.5–106.4% (EP limit: 95–105%)

· The range of free salicylic acid was 0.3% to 1.8% (compared to the pharmacopeial limit of 3%).

· Brands with an enteric coating showed better stability (≤0.5% degradation after 6 months).

· The range in absorbance values was ±1.5% due to excipient interactions, such as those with stearates.

7.3 Vitamin C Brand Evaluation:

Oxidative deterioration has a major effect on the outcomes:

· Batches that are freshly manufactured: 97–103% label claim

· Samples that were incorrectly stored (exposed to heat or light) had potencies as low as 85%.

· At 12 months, blister-packed tablets maintained >95% of their potency, compared to 85–90% in HDPE bottles.

· Formulations including antioxidants, such as citric acid, demonstrated 15% less deterioration than goods sold alone.

7.4 Statistical Assessment:

· No significant inter-brand variations in the API content of paracetamol were found by ANOVA (p < 0.05) (p = 0.12).

· Because of their vulnerability to hydrolysis, aspirin brands displayed a slight degree of heterogeneity (p = 0.03).

· The stability of vitamin C was significantly brand-dependent (p = 0.001).

· Every piece of information satisfied the ICH Q6A requirements for pharmacological equivalency.

8. ADVANTAGES AND LIMITATIONS:

8.1 Benefits of the Calibration Curve Method:

For pharmaceutical analysis, the UV spectrophotometric calibration curve approach provides a number of important advantages:

Cost-Effectiveness: It is 10–15 times more cost-effective than HPLC for routine analysis since it requires

fewer reagents and conventional laboratory equipment⁶.

· High Throughput: With little sample preparation, 50–100 samples can be analyzed simultaneously each day.

· Reproducibility: When appropriate procedures are followed, there is less than 2% inter-operator variability.

· Field Adaptability: In environments with limited resources, on-site testing is made possible with portable UV spectrophotometers.

· Regulatory Acceptance: Adheres to USP <857> and ICH Q2(R1) standards for drug assay validation.

8.2 Limitations and Interferences:

Results may be impacted by matrix effects, solvent interference, and spectral overlap. In subsequent applications, these can be handled by chemometric corrections or derivative spectrophotometry.

9. FUTURE OUTLOOK:

9.1 Machine Learning and Chemometrics:

Artificial intelligence (AI) technologies like as neural networks and partial least squares regression might enhance interpretation, particularly in complicated mixtures or when peaks overlap²⁴.

9.2 Green Analytical Chemistry:

Miniaturized processes, the use of biodegradable solvents, and solvent-free technologies all help to lessen their impact on the environment and assist the Sustainable Development Goals (SDGs).

9.3 Digitalization and Automation:

In pharmaceutical labs, automated sample processing and integration with Laboratory Information Management Systems (LIMS) can reduce human error and increase productivity.

10. CONCLUSION:

A reliable, proven, and easily available method for measuring APIs like paracetamol, aspirin, and vitamin C in commercial formulations is the UV spectrophotometric assay with the calibration curve approach. It is a prominent method in pharmaceutical quality control due to its affordability and regulatory approval. It will continue to be important in the future due to green practices and technology improvements.

11. REFERENCES:

1. Sweetman SC. Martindale: The Complete Drug Reference. 36th ed. Pharmaceutical Press, 2009.

2. Rang HP et al. Rang and Dale’s Pharmacology. 9th ed. Elsevier, 2020.

3. British Pharmacopoeia 2023. UK Medicines and Healthcare products Regulatory Agency.

4. FDA. Analytical Procedures and Methods Validation, Guidance for Industry. 2015.

5. ICH Q2(R1). Validation of Analytical Procedures: Text and Methodology. 2005.

6. Beckett AH, Stenlake JB. Practical Pharmaceutical Chemistry. Vol. 2, 4th ed. CBS Publishers, 2005.

7. Skoog DA et al. Principles of Instrumental Analysis. 6th ed. Cengage Learning. 2007.

8. Harvey D. Modern Analytical Chemistry. McGraw-Hill. 2000.

9. Sharma BK. Instrumental Methods of Chemical Analysis. Krishna Prakashan, 2006.

10. Ahuja S, Scypinski S. Handbook of Modern Pharmaceutical Analysis. Academic Press, 2021.

11. Indian Pharmacopoeia 2022. Indian Pharmacopoeia Commission.

12. USP 2023. United States Pharmacopeia-National Formulary.

13. European Pharmacopoeia 2023. Council of Europe.

14. Snyder LR et al. Introduction to Modern Liquid Chromatography. 3rd ed. Wiley. 2010.

15. Niazi SK. Handbook of Pharmaceutical Manufacturing Formulations. CRC Press. 2019.

16. Ali J et al. UV Spectrophotometric Method for Estimation of Paracetamol. Indian Drugs. 2018.

17. Jain DK et al. Development and Validation of Spectrophotometric Methods for Aspirin. IJPSR. 2019.

18. Ranjith A et al. Simultaneous Estimation of Vitamin C and Paracetamol. J Pharm Sci. 2020.

19. Kumar A et al. Analytical Method Validation Parameters. JAPS, 2021.

20. Bhutkar M et al. UV-Spectroscopic Assay for Combined Dosage Forms. Asian J Pharm, 2021.

21. Sharma K et al. Validation of UV Method for Aspirin. Int J PharmTech Res. 2022.

22. Desai B et al. Method Development Using Beer-Lambert Law. J Anal Chem. 2020.

23. Singh A et al. Pharmaceutical Quality by Design: A Review. IJPER. 2023.

24. Vardhan A et al. Chemometrics in Pharmaceutical Analysis. J Pharm Biomed Anal. 2023.

25. Gaikwad A et al. Green Analytical Chemistry Techniques. Green Chem Lett Rev. 2023.

Received on 30.08.2025 Revised on 18.09.2025

Accepted on 03.10.2025 Published on 08.10.2025

Available online from October 17, 2025

Asian J. Pharm. Tech. 2025; 15(4):421-425.

DOI: 10.52711/2231-5713.2025.00060

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.